Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' disease

Thyroid

Volumn 24, Issue 2, 2014, Pages 347-354

  Boutzios, Georgios ^a   Vasileiadis, Ioannis ^b   Zapanti, Evangelia ^a   Charitoudis, Georgios ^b   Karakostas, Efthimios ^b   Ieromonachou, Panagiotis ^b   Karatzas, Theodore ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Venizeleio Pananeio General Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, PAPILLARY; GRAVES DISEASE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84894147157     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0133     Document Type: Article

References (35)

1. Gerenova J, Buysschaert M, De Burbure CY, Daumerie C 2003 Prevalence of thyroid cancer in Graves' disease: a retrospective study of a cohort of 103 patients treated surgically. Eur J Intern Med 14:321-325.
2. Kraimps JL, Bouin-Pineau MH, Mathonnet M, De Calan L, Ronceray J, Visset J, Marechaud R, Barbier J 2008 Multicentre study of thyroid nodules in patients with Graves' disease. Br J Surg 87:1111-1113.
3. Ozaki O, Ito K, Kobayashi J, Toshima K, Iwasaki H, Yashiro T 1990 Thyroid carcinoma in Graves' disease. World J Surg 14:437-440.
4. Boostrom S, Richards ML 2007 Graves' disease and a thyroid nodule. Otolaryngol Head Neck Surg 136:278-281.
5. Yano Y, Shibuya H, Kitagqawa W, Naqahama M, Suqino K, Ito K, Ito K 2007 Recent outcome of Graves' disease patients with papillary thyroid cancer. Eur J Endocrinol 157:325-329.
6. Tamatea JA, Tuakoi K, Conaglen JV, Elston MS, Meyer-Rochow GY 2012 Thyroid cancer in Graves' disease: is surgery the best treatment for Graves' disease? ANZ J Surg 2012 Sep. 17 [Epub ahead of print]; DOI: 10.1111/j.1445-2197.2012.06233.x.
7. Weber KJ, Solorzano CC, Lee JK, Gaffud MJ, Prinz RA 2006 Thyroidectomy remains an effective treatment option for Graves' disease. Am J Surg 191:400-405.
8. Belfiore A, Garofalo MR, Giuffrida D, Runello F, Filetti S, Fyumara A, Ippolito O, Vigneri R 1990 Increased aggressiveness aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab 70:830-835.
9. Pellegriti G, Belfiore A, Giuffrida D, Lupo L, Vigneri R 1998 Outcome of differentiated thyroid cancer in Graves' disease. J Clin Endocrinol Metab 83:2895-2899.
10. Phitayakorn R, McHenry CR 2008 Incidental thyroid carcinoma in patients with Graves' disease. AmJ Surg 195:292-297.
11. Filetti S, Belfiore A, Amir SM, Daniels GH, Ippolito O, Vigneri R, Ingbar SH 1988 The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer. N Engl J Med 318:753-759.
12. Juhasz F, Boros P, Szegedi G, Balazs G, Suranyi P, Kraszits E, Stenszky V, Farid NR 1989 Immunogenetic and immunologic studies of differentiated thyroid cancer. Cancer 63:1318-1326.
13. Fiumara A, Belfiore A, Russo G, Salomone E, Santonocito GM, Ippolito O, Vigneri R, Gangemi P 1997 In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer. J Clin Endocrinol Metab 82:1615-1620.
14. Boyd CM, Baker JR Jr 1996 The immunology of thyroid cancer. Endocrinol Metab Clin North Am 25:159-179.
15. Ceresini G, Corcione L, Michiara M, Sgargi P, Teresi G, Gilli A, Usberti E, Silini E, Ceda GP 2012 Thyroid cancer incidence by histological type and related variants in mildly iodine-deficient area of Northern Italy, 1998 to 2009. Cancer 118:5473-5480.
16. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in United States, 1973-2002. JAMA 295:2164-2167.
17. Grodski S, Brown T, Sidhu S, Gill A, Robinson B, Learoyd D, Sywak M, Reeve T, Delbridge L 2008 Increased incidence of thyroid cancer is due to increased pathologic detection. Surgery 144:1038-1043.
18. Ghossein R, Livolsi VA 2008 Papillary thyroid carcinoma tall cell variant. Thyroid 18:1179-1181.
19. Rosai J, Carcangiu ML, Delellis RA 1992 Tumors of the Thyroid Gland. Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC, pp 161-182.
20. Sobin LH, Gospodarowicz MK, Wittekind C (Eds) 2009 TNM Classification of Malignant Tumours, 7th ed. John Wiley & Sons/UICC, New York.
21. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, Mclver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
22. Silver CE, Owen RP, Rodrigo JP, Rinaldo A, Devaney KO, Ferlito A 2010 Aggressive variants of papillary thyroid carcinoma. Head Neck 33:1052-1059.
23. Carling T, Ocal I, Udelsman R 2007 Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer? World J Surg 31:916-923.
24. Khanafshar E, Lloyd RV 2011 The spectrum of papillary thyroid carcinoma variants. Adv Anat Pathol 18:90-97.
25. Hay ID, Hutchinson ME, Gonzalez-Losada T, Mclver B, Reinalda ME, Grant CS, Thompson GB, Sebo TJ, Goellner JR 2008 Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980-988.
26. Vasileiadis I, Karakostas E, Charitoudis G, Stavrianaki A, Kapetanakis S, Kouraklis G, Karatzas T 2012 Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients. Eur J Clin Invest 42:657-664.
27. Kazaure HS, Roman SA, Sosa JA 2012 Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43, 738 patients. Ann Surg Oncol 19:1874-1880.
28. Carling T, Ocal IT, Udelsman R 2007 Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer? World J Surg 31:916-923.
29. Pilotti S, Collini P, Manzari A, Marubini E, Rilke F 1995 Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns? Semin Diagn Pathol 12:249-255.
30. Morris LG, Shaha AR, Tuttle RM, Sikora AG, Ganly I 2010 Tall-cell variant of papillary thyroid carcinoma: a matchedpair analysis of survival. Thyroid 10:153-158.
31. Leung AK, Chow SM, Law SC 2008 Clinical features and outcomes of the tall cell variant of papillary thyroid carcinoma. Laryngoscope 118:32-38.
32. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi A, Matsuzuka F, Kuma S, Kuma K, Kakudo K 2004 Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg 28:1115-1121.
33. McDougall IR, Camargo CA 2007 In my view. Treatment of micropapillary carcinoma of thyroid: where do we draw the line? Thyroid 32:279-281.
34. Jalisi S, Ainsworth T, La Valley M 2010 Prognostic outcomes of tall cell variant papillary thyroid cancer: a meta-analysis. J Thyroid Res 2010:325602.
35. Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA 2006 Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107:1255-1264.